IP Library Granted Patent US 8,182,999
Granted Patent B2
US 8,182,999 · App. 12/825,223 · Granted May 22, 2012

Compositions and methods for early pregnancy diagnosis

Assignee: The Curators of the University of Missouri
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,182,999
App. No.
12/825,223
Granted
May 22, 2012
Kind
B2
Abstract

Pregnancy-associated glycoproteins (PAGs) are structurally related to the pepsins, thought to be restricted to the hoofed (ungulate) mammals and characterized by being expressed specifically in the outer epithelial cell layer (chorion/trophectoderm) of the placenta. By cloning expressed genes from ovine and bovine placental cDNA libraries, the inventors estimate that cattle, sheep, and most probably all ruminant Artiodactyla, possess possibly 100 or more PAG genes, many of which are placentally expressed. The PAGs are highly diverse in sequence, with regions of hypervariability confined largely to surface-exposed loops. Selected PAG that are products of the invasive binucleate cells, expressed highly in early pregnancy at the time of trophoblast invasion and expressed weakly, if at all, in late gestation are useful in the early diagnosis of pregnancy. In a preferred embodiment, the invention relates to immunoassays for detecting these PAGs.

Claims (17)

1. A method for detecting pregnancy in a bovine animal comprising:

(a) obtaining a sample from said animal; and

(b) detecting at least one pregnancy associated antigen (PAG) wherein said PAG is selected from the group consisting of BoPAG5, BoPAG9, BoPAG15, BoPAG18, and BoPAG19; wherein the PAG is present in early pregnancy and absent at about two months post-partum;

whereby the presence of the PAG indicates that said animal is pregnant.

2. The method of claim 1 , wherein said sample is saliva, serum, blood, milk or urine.

3. The method of claim 1 , wherein said detecting comprises immunologic detection.

4. The method of claim 3 , wherein said immunologic detection comprises detection with polyclonal antisera or with a monoclonal antibody preparation.

5. The method of claim 3 , wherein said immunologic detection comprises ELISA, RIA or Western blot.

6. The method of claim 1 , wherein the PAG is BoPAG5.

7. The method of claim 1 , further comprising detecting a second or third PAG in said sample.

8. The method of claim 5 , wherein said ELISA is a sandwich ELISA comprising binding of a PAG to a first antibody preparation fixed to a substrate and a second antibody preparation labeled with an enzyme.

9. The method of claim 8 , wherein said enzyme is alkaline phosphatase or horseradish peroxidase.

10. The method of claim 8 , wherein said first antibody preparation is monoclonal.

11. The method of claim 1 , wherein the PAG is BoPAG9.

12. The method of claim 1 , wherein the PAG is BoPAG15.

13. The method of claim 1 , wherein the PAG is BoPAG18.

14. The method of claim 1 , wherein the PAG is BoPAG19.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 20, 2012
From: UNIVERSITY OF MISSOURI COLUMBIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029017/0858 →
Continuity (6)
Continuation 11552454 · Oct 24, 2006
Division 10655547 · Sep 4, 2003
Continuation 09273164 · Mar 19, 1999
Provisional Application 60078783 · Mar 20, 1998
Provisional Application 60106188 · Oct 28, 1998
Related Publication 20100331206A1 · Dec 30, 2010